Status:
COMPLETED
Effectiveness Of Expectant Management In The Tubal Ectopic Pregnancy
Lead Sponsor:
Federal University of São Paulo
Conditions:
Ectopic Pregnancy
Eligibility:
FEMALE
18+ years
Phase:
PHASE4
Brief Summary
Objectives: To evaluate if, when considering expectant management in tubal ectopic pregnancy if the complementary use of Methotrexate could provide better results. We evaluate the success of treatment...
Eligibility Criteria
Inclusion
- Hemodynamic stability
- Initial β-hCG \<2000 mIU / mL
- Titers of β-hCG in decline in 48 hours before treatment
- Adnexal mass \<5.0 cm
- Desire for future pregnancy
Exclusion
- Alive embryo
- Ectopic pregnancy other than in tubal location
- Pregnancy of unknown location
Key Trial Info
Start Date :
September 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2013
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT01876004
Start Date
September 1 2011
End Date
June 1 2013
Last Update
June 12 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Federal University of Sao Paulo
São Paulo, São Paulo, Brazil